Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
European Urology|October 8, 2025
Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 StudySiamak Daneshmand, Renata Zaucha, James W F Catto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell CarcinomaRobert A Figlin, Nizar M Tannir, Robert G Uzzo, et al.
Clinical Genitourinary Cancer|May 11, 2024
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC RegistryCesare Saitta, Jonathan A Afari, Dattatraya Patil, et al.
Urologic Oncology|April 22, 2025
Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinomaGiacomo Musso, Margaret F Meagher, Kit L Yuen, et al.
Clinical Genitourinary Cancer|November 24, 2025
Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter AnalysisMai R Dabbas, Melis Guer, Giacomo Musso, et al.
European Urology Oncology|August 19, 2025
Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell CarcinomaCristiane D Bergerot, David Cella, Paulo G Bergerot, et al.
Clinical Genitourinary Cancer|July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) RegistryJulian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
Cancers|May 13, 2026
C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell CarcinomaAaron I Ahdoot, Cesare Saitta, Giuseppe Garofano, et al.
The Lancet. Oncology|September 13, 2024
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.
Pageof 9